Perioperative blood transfusion has a dose-dependent relationship with disease recurrence and survival in patients with non–small cell lung cancer

Journal of Thoracic and Cardiovascular Surgery

Volumn 157, Issue 6, 2019, Pages 2469-2477.e10

  Latif, M Jawad ^a   Tan, Kay See ^a   Molena, Daniela ^a   Huang, James ^a   Bott, Matthew J ^a   Park, Bernard J ^a   Adusumilli, Prasad S ^a   Rusch, Valerie W ^a   Bains, Manjit S ^a   Downey, Robert J ^a   Jones, David R ^a   Isbell, James M ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

lobectomy; lung cancer; propensity score matching; recurrence; segmentectomy; survival; transfusion

Indexed keywords

ANTINEOPLASTIC AGENT;

ADENOSQUAMOUS CARCINOMA; ADJUVANT RADIOTHERAPY; ADJUVANT THERAPY; AGED; ARTICLE; BILOBECTOMY; BLOOD TRANSFUSION; CANCER PATIENT; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; COHORT ANALYSIS; COLLOID CARCINOMA; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE FREE SURVIVAL; ERYTHROCYTE TRANSFUSION; FEMALE; FOLLOW UP; HISTOLOGY; HUMAN; LARGE CELL LUNG CARCINOMA; LOBECTOMY; LUNG ADENOCARCINOMA; LUNG RESECTION; MAJOR CLINICAL STUDY; MALE; NEOADJUVANT CHEMOTHERAPY; NON SMALL CELL LUNG CANCER; OVERALL SURVIVAL; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; RECURRENT DISEASE; SEGMENTECTOMY; SQUAMOUS CELL LUNG CARCINOMA; EPIDEMIOLOGY; LUNG TUMOR; MIDDLE AGED; MORTALITY; PROPENSITY SCORE; RETROSPECTIVE STUDY; STATISTICAL MODEL; TUMOR RECURRENCE;

AGED; BLOOD TRANSFUSION; CARCINOMA, NON-SMALL-CELL LUNG; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LOGISTIC MODELS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PERIOPERATIVE PERIOD; PROPENSITY SCORE; RETROSPECTIVE STUDIES;

EID: 85062275228     PISSN: 00225223     EISSN: 1097685X     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2018.12.109     Document Type: Article

References (25)

1. Nosotti, M., Rebulla, P., Riccardi, D., Baisi, A., Bellaviti, N., Rosso, L., et al. Correlation between perioperative blood transfusion and prognosis of patients subjected to surgery for stage I lung cancer. Chest 124 (2003), 102–107.
2. Ng, T., Ryder, B.A., Chern, H., Sellke, F.W., Machan, J.T., Harrington, D.T., et al. Leukocyte-depleted blood transfusion is associated with decreased survival in resected early-stage lung cancer. J Thorac Cardiovasc Surg 143 (2012), 815–819.
3. Moores, D.W., Piantadosi, S., McKneally, M.F., Effect of perioperative blood transfusion on outcome in patients with surgically resected lung cancer. Ann Thorac Surg 47 (1989), 346–351.
4. Piantadosi, S., Moores, D.W., McKneally, M.F., The adverse effect of perioperative blood transfusion in lung cancer. Chest 106 (1994), 382S–384S.
5. Wang, T., Luo, L., Huang, H., Yu, J., Pan, C., Cai, X., et al. Perioperative blood transfusion is associated with worse clinical outcomes in resected lung cancer. Ann Thorac Surg 97 (2014), 1827–1837.
6. Keller, S.M., Groshen, S., Martini, N., Kaiser, L.R., Blood transfusion and lung cancer recurrence. Cancer 62 (1988), 606–610.
7. Thomas, P., Michelet, P., Barlesi, F., Thirion, X., Doddoli, C., Giudicelli, R., et al. Impact of blood transfusions on outcome after pneumonectomy for thoracic malignancies. Eur Respir J 29 (2007), 565–570.
8. Cata, J.P., Gutierrez, C., Mehran, R.J., Rice, D., Nates, J., Feng, L., et al. Preoperative anemia, blood transfusion, and neutrophil-to-lymphocyte ratio in patients with stage i non-small cell lung cancer. Cancer Cell Microenviron, 3, 2016, e1116.
9. Boffa, D.J., Allen, M.S., Grab, J.D., Gaissert, H.A., Harpole, D.H., Wright, C.D., Data from the Society of Thoracic Surgeons General Thoracic Surgery database: the surgical management of primary lung tumors. J Thorac Cardiovasc Surg 135 (2008), 247–254.
10. Psaty, B.M., Koepsell, T.D., Lin, D., Weiss, N.S., Siscovick, D.S., Rosendaal, F.R., et al. Assessment and control for confounding by indication in observational studies. J Am Geriatr Soc 47 (1999), 749–754.
11. Edge, S., Byrd, D.R., Compton, C.C., Fritz, A.G., Greene, F., Trotti, A., American Joint Committee on Cancer Cancer Staging Manual. 7th ed., 2009, Springer, New York, NY.
12. McMahon, A.D., Approaches to combat with confounding by indication in observational studies of intended drug effects. Pharmacoepidemiol Drug Saf 12 (2003), 551–558.
13. Nitadori, J., Bograd, A.J., Kadota, K., Sima, C.S., Rizk, N.P., Morales, E.A., et al. Impact of micropapillary histologic subtype in selecting limited resection vs lobectomy for lung adenocarcinoma of 2cm or smaller. J Natl Cancer Inst 105 (2013), 1212–1220.
14. Katz, N.M., The evolution of cardiothoracic critical care. J Thorac Cardiovasc Surg 141 (2011), 3–6.
15. Satagopan, J.M., Ben-Porat, L., Berwick, M., Robson, M., Kutler, D., Auerbach, A.D., A note on competing risks in survival data analysis. Br J Cancer 91 (2004), 1229–1235.
16. Li, L., Greene, T., A weighting analogue to pair matching in propensity score analysis. Int J Biostat 9 (2013), 215–234.
17. Austin, P.C., An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivariate Behav Res 46 (2011), 399–424.
18. van Buuren, S., Groothuis-Oudshoorn, C.G.M., mice: multivariate imputation by chained equations in R. J Stat Softw, 45, 2011.
19. Moons, K.G., Donders, R.A., Stijnen, T., Harrell, F.E. Jr., Using the outcome for imputation of missing predictor values was preferred. J Clin Epidemiol 59 (2006), 1092–1101.
20. Rubin, D., Multiple Imputation for Nonresponse in Surveys. 1987, John Wiley and Sons, New York.
21. Little, A.G., Wu, H.S., Ferguson, M.K., Ho, C.H., Bowers, V.D., Segalin, A., et al. Perioperative blood transfusion adversely affects prognosis of patients with stage I non-small-cell lung cancer. Am J Surg 160 (1990), 630–632 discussion 633.
22. Cata, J.P., Chukka, V., Wang, H., Feng, L., Gottumukkala, V., Martinez, F., et al. Perioperative blood transfusions and survival in patients with non-small cell lung cancer: a retrospective study. BMC Anesthesiol, 13, 2013, 42.
23. Churchhouse, A.M., Mathews, T.J., McBride, O.M., Dunning, J., Does blood transfusion increase the chance of recurrence in patients undergoing surgery for lung cancer?. Interact Cardiovasc Thorac Surg 14 (2012), 85–90.
24. Eguchi, T., Bains, S., Lee, M.C., Tan, K.S., Hristov, B., Buitrago, D.H., et al. Impact of increasing age on cause-specific mortality and morbidity in patients with stage I non-small-cell lung cancer: a competing risks analysis. J Clin Oncol 35 (2017), 281–290.
25. Ginsberg, R.J., Rubinstein, L.V., Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung cancer study group. Ann Thorac Surg 60 (1995), 615–622 discussion 622-3.